{
    "2019-09-04": [
        [
            {
                "time": "2018-09-09",
                "original_text": "外包行业09/09：创新药申报高景气，关注CMO产能转移趋势",
                "features": {
                    "keywords": [
                        "外包行业",
                        "创新药",
                        "CMO",
                        "产能转移"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "3亿美元可转债在途 药明康德意欲加码并购和业务扩张",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转债",
                        "并购",
                        "业务扩张"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "药明康德拟向专业投资者发行美元可转债",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转债",
                        "专业投资者"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "医药外包龙头从β到α的路径展望",
                "features": {
                    "keywords": [
                        "医药外包",
                        "龙头",
                        "β到α"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "中国市场红利逻辑下，医药外包公司弹性不一样",
                "features": {
                    "keywords": [
                        "中国市场",
                        "红利",
                        "医药外包",
                        "弹性"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-13",
                "original_text": "康龙化成：能力边界突破、规模性逐步体现的全球化CRO公司",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "能力边界",
                        "全球化",
                        "CRO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "药明康德(603259.SH)拟发行3亿美元2024年到期零息可转债",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转债",
                        "零息",
                        "2024年到期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "药明康德(02359-HK)拟发3亿美元零息可转换债券因股价有溢价30%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转换债券",
                        "零息",
                        "溢价30%"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-16",
                "original_text": "药明康德(02359.HK)拟发行3亿美元零息可转债",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转债",
                        "零息",
                        "3亿美元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}